Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Molecular genetic basis of Gilbert's syndrome.

Burchell B, Hume R.

J Gastroenterol Hepatol. 1999 Oct;14(10):960-6. Review.

PMID:
10530490
2.

[From gene to disease; unconjugated hyperbilirubinemia: Gilbert's syndrome and Crigler-Najjar types I and II].

Drenth JP, Peters WH, Jansen JB.

Ned Tijdschr Geneeskd. 2002 Aug 10;146(32):1488-90. Review. Dutch.

PMID:
12198827
3.

Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases.

Burchell B, Soars M, Monaghan G, Cassidy A, Smith D, Ethell B.

Toxicol Lett. 2000 Mar 15;112-113:333-40. Review.

PMID:
10720749
4.

Assessment of UGT polymorphisms and neonatal jaundice.

Bartlett MG, Gourley GR.

Semin Perinatol. 2011 Jun;35(3):127-33. doi: 10.1053/j.semperi.2011.02.006. Review.

PMID:
21641485
5.

Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia.

Fujiwara R, Maruo Y, Chen S, Tukey RH.

Toxicol Appl Pharmacol. 2015 Nov 15;289(1):124-32. doi: 10.1016/j.taap.2015.08.018. Epub 2015 Sep 2. Review.

6.

Pharmacogenetics of Gilbert's syndrome.

Strassburg CP.

Pharmacogenomics. 2008 Jun;9(6):703-15. doi: 10.2217/14622416.9.6.703. Review.

PMID:
18518849
7.

Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.

Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR.

Hum Mutat. 2000 Oct;16(4):297-306. Review.

PMID:
11013440
8.

Molecular pathology of Crigler-Najjar type I and II and Gilbert's syndromes.

Sampietro M, Iolascon A.

Haematologica. 1999 Feb;84(2):150-7. Review.

9.

[Gilbert's syndrome--myths and reality].

Muchová L, Kráslová I, Lenícek M, Vítek L.

Cas Lek Cesk. 2004;143(6):375-80. Review. Czech.

PMID:
15309863
10.

Gilbert's syndrome: an overview for clinical biochemists.

Hirschfield GM, Alexander GJ.

Ann Clin Biochem. 2006 Sep;43(Pt 5):340-3. Review.

PMID:
17022875
11.

Gilbert's syndrome and drug metabolism.

Macklon AF, Savage RL, Rawlins MD.

Clin Pharmacokinet. 1979 May-Jun;4(3):223-32. Review.

PMID:
383356
12.

Function, genetic polymorphism, and transcriptional regulation of human UDP-glucuronosyltransferase (UGT) 1A1.

Sugatani J.

Drug Metab Pharmacokinet. 2013;28(2):83-92. Epub 2012 Oct 23. Review.

13.

Gilbert syndrome.

Fretzayas A, Moustaki M, Liapi O, Karpathios T.

Eur J Pediatr. 2012 Jan;171(1):11-5. doi: 10.1007/s00431-011-1641-0. Epub 2011 Dec 9. Review.

PMID:
22160004
14.

[Gilbert syndrome].

Faragó B, Melegh B.

Orv Hetil. 2008 Jul 6;149(27):1277-82. doi: 10.1556/OH.2008.28381. Review. Hungarian.

PMID:
18579467
16.

Gilbert syndrome: the UGT1A1*28 promoter polymorphism as a biomarker of multifactorial diseases and drug metabolism.

Gil J, Sąsiadek MM.

Biomark Med. 2012 Apr;6(2):223-30. doi: 10.2217/BMM.12.4. Review.

PMID:
22448797
17.

GILBERT'S SYNDROME - A CONCEALED ADVERSITY FOR PHYSICIANS AND SURGEONS.

Rasool A, Sabir S, Ashlaq M, Farooq U, Khan MZ, Khan FY.

J Ayub Med Coll Abbottabad. 2015 Jul-Sep;27(3):707-10. Review.

PMID:
26721045
18.

[UDP-glucuronosyltransferase].

Maruo Y, Sato H.

Nihon Eiseigaku Zasshi. 2002 Jan;56(4):629-33. Review. Japanese.

PMID:
11868392
19.

Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert's syndrome?

Kundur AR, Singh I, Bulmer AC.

Atherosclerosis. 2015 Mar;239(1):73-84. doi: 10.1016/j.atherosclerosis.2014.12.042. Epub 2014 Dec 24. Review.

PMID:
25576848
20.

Gilbert's syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II).

Perrotta S, del Giudice EM, Carbone R, Servedio V, Schettini F Jr, Nobili B, Iolascon A.

J Pediatr. 2000 Apr;136(4):556-9. Review.

PMID:
10753261

Supplemental Content

Support Center